Acetylcholine and attention

Behavioural Brain Research

Volumn 221, Issue 2, 2011, Pages 430-442

  Klinkenberg, Inge ^a   Sambeth, Anke ^a   Blokland, Arjan ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cognition; Imaging; Lesion; Microdialysis; Muscarinic; Nicotinic

Indexed keywords

ACETYLCHOLINE; MUSCARINIC RECEPTOR; NICOTINE; SCOPOLAMINE;

ACETYLCHOLINE RELEASE; ATTENTION; BRAIN CORTEX; BRAIN FUNCTION; BRAIN PARIETOFRONTAL CORTEX; BRAIN REGION; CHOLINERGIC SYSTEM; COGNITION; DRUG EFFICACY; DRUG MEGADOSE; FRONTAL CORTEX; HUMAN; LEARNING; LEARNING DISORDER; MEMORY DISORDER; NONHUMAN; PARASYMPATHETIC INNERVATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BLOCKING; REVIEW; SHORT TERM MEMORY; SOMATOSENSORY CORTEX; STIMULUS RESPONSE; TASK PERFORMANCE; VISUAL CORTEX;

ACETYLCHOLINE; ANIMALS; ATTENTION; BRAIN; BRAIN MAPPING; CEREBRAL CORTEX; CHOLINERGIC AGENTS; CHOLINERGIC FIBERS; COGNITION; HUMANS; MEMORY; MODELS, NEUROLOGICAL;

EID: 79955720765     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.11.033     Document Type: Review

References (155)

1. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 217:408-417.
2. Bartus R.T., Dean R.L., Pontecorvo M.J., Flicker C. The cholinergic hypothesis: a historical overview, current perspective, and future directions. Ann N Y Acad Sci 1985, 444:332-358.
3. Klinkenberg I., Blokland A. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev 2010, 34:1307-1350.
4. Gauthier S., Scheltens P. Can we do better in developing new drugs for Alzheimer's disease?. Alzheimer's Dement 2009, 5:489-491.
5. Lockhart I.A., Mitchell S.A., Kelly S. Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence. Dement Geriatr Cogn Disord 2009, 28:389-403.
6. Cincotta S.L., Yorek M.S., Moschak T.M., Lewis S.R., Rodefer J.S. Selective nicotinic acetylcholine receptor agonists: potential therapies for neuropsychiatric disorders with cognitive dysfunction. Curr Opin Investig Drugs 2008, 9:47-56.
7. Leiser S.C., Bowlby M.R., Comery T.A., Dunlop J. A cog in cognition: how the alpha7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits. Pharmacol Ther 2009, 122:302-311.
8. Feuerbach D., Lingenhoehl K., Olpe H.R., Vassout A., Gentsch C., Chaperon F., et al. The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain. Neuropharmacology 2009, 56:254-263.
9. Jakubik J., Michal P., Machova E., Dolezal V. Importance and prospects for design of selective muscarinic agonists. Physiol Res 2008, 57(Suppl. 3):S39-S47.
10. Bradley S.R., Lameh J., Ohrmund L., Son T., Bajpai A., Nguyen D., et al. AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model. Neuropharmacology 2010, 58:365-373.
11. Blokland A. Acetylcholine: a neurotransmitter for learning and memory?. Brain Res Rev 1995, 21:285-300.
12. Muir J.L. Acetylcholine, aging, and Alzheimer's disease. Pharmacol Biochem Behav 1997, 56:687-696.
13. Rasmusson D.D. The role of acetylcholine in cortical synaptic plasticity. Behav Brain Res 2000, 115:205-218.
14. Sarter M., Bruno J.P. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res Rev 1997, 23:28-46.
15. McGaughy J., Everitt B.J., Robbins T.W., Sarter M. The role of cortical cholinergic afferent projections in cognition: impact of new selective immunotoxins. Behav Brain Res 2000, 115:251-263.
16. Parikh V., Kozak R., Martinez V., Sarter M. Prefrontal acetylcholine release controls cue detection on multiple timescales. Neuron 2007, 56:141-154.
17. Goard M., Dan Y. Basal forebrain activation enhances cortical coding of natural scenes. Nat Neurosci 2009, 12:1440-1447.
18. Parasuraman R., Greenwood P.M., Kumar R., Fossella J. Beyond heritability: neurotransmitter genes differentially modulate visuospatial attention and working memory. Psychol Sci 2005, 16:200-207.
19. Wiley R.G. Neural lesioning with ribosome-inactivating proteins: suicide transport and immunolesioning. Trends Neurosci 1992, 15:285-290.
20. Torres E.M., Perry T.A., Blokland A., Wilkinson L.S., Wiley R.G., Lappi D.A., et al. Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience 1994, 63:95-122.
21. Baxter M., Gallagher M. Intact spatial learning in both young and aged rats following selective removal of hippocampal cholinergic input. Behav Neurosci 1996, 110:460-467.
22. McMahan R.W., Sobel T.J., Baxter M.G. Selective immunolesions of hippocampal cholinergic input fail to impair spatial working memory. Hippocampus 1997, 7:130-136.
23. Waite J.J., Chen A.D., Wardlow M.L., Wiley R.G., Lappi D.A., Thal L.J. 192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells. Neuroscience 1995, 65:463-476.
24. Harati H., Barbelivien A., Cosquer B., Majchrzak M., Cassel J.C. Selective cholinergic lesions in the rat nucleus basalis magnocellularis with limited damage in the medial septum specifically alter attention performance in the five-choice serial reaction time task. Neuroscience 2008, 153:72-83.
25. Fletcher B.R., Baxter M.G., Guzowski J.F., Shapiro M.L., Rapp P.R. Selective cholinergic depletion of the hippocampus spares both behaviorally induced Arc transcription and spatial learning and memory. Hippocampus 2007, 17:227-234.
26. Perry T., Hodges H., Gray J.A. Behavioural, histological and immunocytochemical consequences following 192 IgG-saporin immunolesions of the basal forebrain cholinergic system. Brain Res Bull 2001, 29-48.
27. van der Staay F.J., Bouger P., Lehmann O., Lazarus C., Cosquer B., Koenig J., et al. Long-term effects of immunotoxic cholinergic lesions in the septum on acquisition of the cone-field task and noncognitive measures in rats. Hippocampus 2006, 16:1061-1079.
28. Fitz N.F., Gibbs R.B., Johnson D.A. Selective lesion of septal cholinergic neurons in rats impairs acquisition of a delayed matching to position T-maze task by delaying the shift from a response to a place strategy. Brain Res Bull 2008, 77:356-360.
29. Lehmann O., Grottick A.J., Cassel J.C., Higgins G.A. A double dissociation between serial reaction time and radial maze performance in rats subjected to 192 IgG-saporin lesions of the nucleus basalis and/or the septal region. Eur J Neurosci 2003, 18:651-666.
30. Fitz N.F., Gibbs R.B., Johnson D.A. Aversive stimulus attenuates impairment of acquisition in a delayed match to position T-maze task caused by a selective lesion of septo-hippocampal cholinergic projections. Brain Res Bull 2006, 69:660-665.
31. Pioro E.P., Cuello A.C. Purkinje cells of adult rat cerebellum express nerve growth factor receptor immunoreactivity: light microscopic observations. Brain Res 1988, 455:182-186.
32. Moreau P.H., Cosquer B., Jeltsch H., Cassel J.C., Mathis C. Neuroanatomical and behavioral effects of a novel version of the cholinergic immunotoxin mu p75-saporin in mice. Hippocampus 2008, 610-622.
33. Nag N., Baxter M.G., Berger-Sweeney J.E. Efficacy of a murine-p75-saporin immunotoxin for selective lesions of basal forebrain cholinergic neurons in mice. Neurosci Lett 2009, 452:247-251.
34. Baxter M.G., Holland P.C., Gallagher M. Disruption of decrements in conditioned stimulus processing by selective removal of hippocampal cholinergic input. J Neurosci 1997, 17:5230-5236.
35. Lecourtier L, de Vasconcelos AP, Leroux E, Cosquer B, Geiger K, Lithfous S, et al. Septohippocampal pathways contribute to system consolidation of a spatial memory: sequential implication of gabaergic and cholinergic neurons. Hippocampus (2010), doi:10.1002/hipo.20837.
36. Newman L.A., McGaughy J. Cholinergic deafferentation of prefrontal cortex increases sensitivity to cross-modal distractors during a sustained attention task. J Neurosci 2008, 28:2642-2650.
37. Dalley J.W., Theobald D.E., Bouger P., Chudasama Y., Cardinal R.N., Robbins T.W. Cortical cholinergic function and deficits in visual attentional performance in rats following 192 IgG-saporin-induced lesions of the medial prefrontal cortex. Cereb Cortex 2004, 14:922-932.
38. Bucci D.J., Holland P.C., Gallagher M. Removal of cholinergic input to rat posterior parietal cortex disrupts incremental processing of conditioned stimuli. J Neurosci 1998, 18:8038-8046.
39. Winters B.D., Robbins T.W., Everitt B.J. Selective cholinergic denervation of the cingulate cortex impairs the acquisition and performance of a conditional visual discrimination in rats. Eur J Neurosci 2004, 19:490-496.
40. McGaughy J., Koene R.A., Eichenbaum H., Hasselmo M.E. Cholinergic deafferentation of the entorhinal cortex in rats impairs encoding of novel but not familiar stimuli in a delayed nonmatch-to-sample task. J Neurosci 2005, 25:10273-10281.
41. Sarter M., Bruno J.P., Givens B., Moore H., McGaughy J., McMahon K. Neuronal mechanisms mediating drug-induced cognition enhancement: cognitive activity as a necessary intervening variable. Cognitive Brain Res 1996, 3:329-343.
42. Moore H., Sarter M., Bruno J.P. Age-dependent modulation of in vivo cortical acetylcholine release by benzodiazepine receptor ligands. Brain Res 1992, 596:17-29.
43. Inglis F.M., Day J.C., Fibinger H.C. Enhanced acetylcholine release in hippocampus and cortex during the anticipation and consumption of a palatable meal. Neuroscience 1994, 62:1049-1056.
44. Day J., Damsma G., Fibiger H.C. Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: an in vivo microdialysis study. Pharmacol Biochem Behav 1991, 38:723-729.
45. Dudar J.D., Wishaw I.Q., Szerb J.C. Release of acetylcholine from the hippocampus of freely moving rats during sensory stimulation and running. Neuropsychopharmacology 1979, 18:673-678.
46. Nilsson O.G., Kalen P., Rosengren E., Björklund A. Acetylcholine release in the rat hippocampus as studied by microdialysis is dependent on axonal impulse flow and increases during behavioural activation. Neuroscience 1990, 36:325-338.
47. Himmelheber A.M., Sarter M., Bruno J.P. Operant performance and cortical acetylcholine release: role of response rate, reward density, and non-contingent stimuli. Cognitive Brain Res 1997, 6:23-26.
48. Parikh V., Sarter M. Cholinergic mediation of attention: contributions of phasic and tonic increases in prefrontal cholinergic activity. Ann N Y Acad Sci 2008, 1129:225-235.
49. Sarter M., Parikh V., Howe W.M. Phasic acetylcholine release and the volume transmission hypothesis: time to move on. Nat Rev Neurosci 2009, 10:383-390.
50. Passetti F., Dalley J.W., O'Connell M.T., Everitt B.J., Robbins T.W. Increased acetylcholine release in the rat medial prefrontal cortex during performance of a visual attentional task. Eur J Neurosci 2000, 12:3051-3058.
51. Dalley J.W., McGaughy J., O'Connell M.T., Cardinal R.N., Levita L., Robbins T.W. Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and noncontingent performance of a visual attentional task. J Neurosci 2001, 21:4908-4914.
52. Acquas E., Wilson C., Fibiger H.C. Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation, and fear. J Neurosci 1996, 16:3089-3096.
53. Nail-Boucherie K., Dourmap N., Jaffard R., Costentin J. Contextual fear conditioning is associated with an increase of acetylcholine release in the hippocampus of rat. Cognitive Brain Res 2000, 9:193-197.
54. Hata T., Kumai K., Okaichi H. Hippocampal acetylcholine efflux increases during negative patterning and elemental discrimination in rats. Neurosci Lett 2007, 418:127-132.
55. Thiel C.M., Huston J.P., Schwarting R.K.W. Cholinergic activation in frontal cortex and nucleus accumbens related to basic behavioral manipulations: handling, and the role of post-handling experience. Brain Res 1998, 812:121-132.
56. Inglis F.M., Fibinger H.C. Ìncreases in hippocampal and frontal cortical acetylcholine release associated with presentation of sensory stimuli. Neuroscience 1995, 66:81-86.
57. Giovannini M.G., Rakovska A., Benton R.S., Pazzagli M., Bianchi L., Pepeu G. Effects of novelty and habituation on acetylcholine, GABA, and glutamate release from the frontal cortex and hippocampus of freely moving rats. Neuroscience 2001, 106:43-53.
58. Himmelheber A.M., Sarter M., Bruno J.P. Increases in cortical acetylcholine release during sustained attention performance in rats. Cognitive Brain Res 2000, 9:313-325.
59. Himmelheber A.M., Sarter M., Bruno J.P. The effects of manipulations of attentional demand on cortical acetylcholine release. Cognitive Brain Res 2001, 12:353-370.
60. Arnold H.M., Burk J.A., Hodgson E.M., Sarter M., Bruno J.P. Differential cortical acetylcholine release in rats performing a sustained attention task versus behavioral control tasks that do not explicitly task attention. Neuroscience 2002, 114:451-460.
61. Fournier G.N., Semba K., Rasmusson D.D. Modality- and region-specific acetylcholine release in the rat neocortex. Neuroscience 2004, 126:257-262.
62. Kozak R., Bruno J.P., Sarter M. Augmented prefrontal acetylcholine release during challenged attentional performance. Cereb Cortex 2006, 16:9-17.
63. Hasselmo M.E. The role of acetylcholine in learning and memory. Curr Opin Neurobiol 2006, 16:710-715.
64. Davidson M.C., Marrocco R.T. Local infusion of scopolamine into intraparietal cortex slows covert orienting in rhesus monkeys. J Neurophysiol 2000, 83:1536-1549.
65. Robbins T.W., Granon S., Muir J.L., Durantou F., Harrison A., Everitt B.J. Neural systems underlying arousal and attention: implications for drug abuse. Ann N Y Acad Sci 1998, 846:222-237.
66. Barak S., Weiner I. Differential role of muscarinic transmission within the entorhinal cortex and basolateral amygdala in the processing of irrelevant stimuli. Neuropsychopharmacology 2010, 35:1073-1082.
67. Herrerro J.L., Roberts M.J., Delicato L.S., Gieselmann M.A., Dayan P., Thiele A. Acetylcholine contributes through muscarinic receptors to attentional modulation in V1. Nature 2008, 454:1110-1114.
68. Broersen L.M., Heinsbroek R.P.W., de Bruin J.P.C., Joosten R.N.J., van Hest A., Olivier B. Effects of local application of dopaminergic drugs into the dorsal part of the medial prefrontal cortex of rats in a delayed matching to position task: comparison with local cholinergic blockade. Brain Res 1994, 645:113-122.
69. Dunnett S.B., Wareham A.T., Torres E.M. Cholinergic blockade in prefrontal cortex and hippocampus disrupts short-term memory in rats. Neuroreport 1990, 1:61-64.
70. Herremans A.H.J., Hijzen T.H., Welborn P.F.E., Olivier B., Slangen J.L. Effects of infusion of cholinergic drugs into the prefrontal cortex area on delayed matching to position performance in the rat. Brain Res 1996, 711:102-111.
71. Granon S., Poucet B., Thinus-Blanc C., Changeux J.-P., Vidal C. Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing. Psychopharmacology (Berl) 1995, 119:139-144.
72. Wall P.M., Flinn J., Messier C. Infralimbic muscarinic M1 receptors modulate anxiety-like behaviour and spontaneous working memory in mice. Psychopharmacology (Berl) 2001, 155:58-68.
73. Winters B.D., Saksida L.M., Bussey T.J. Paradoxical facilitation of object recognition memory after infusion of scopolamine into perirhinal cortex: implications for cholinergic system function. J Neurosci 2006, 26:9520-9529.
74. Abe H., Ishida Y., Iwasaki T. Perirhinal N-methyl-d-aspartate and muscarinic systems participate in object recognition in rats. Neurosci Lett 2004, 356:191-194.
75. Warburton E.C., Koder T., Kwangwook C., Massey P.V., Duguid G., Barker G.R.I., et al. Cholinergic neurotransmission is essential for perirhinal cortical plasticity and recognition memory. Neuron 2003, 38:987-996.
76. Santucci A.C., Shaw C. Peripheral 8-OH-DPAT and scopolamine infused into the frontal cortex produce passive avoidance retention impairments in rats. Neurobiol Learn Mem 2003, 79:136-141.
77. Wilson D.A. Scopolamine enhances generalization between odor representations in rat olfactory cortex. Learn Mem 2001, 8:279-285.
78. Herremans A.H.J., Hijzen T.H., Olivier B. Effects of cholinergic drug infusions into the dorsal part of the medial prefrontal cortex on delayed conditional discrimination peformance in the rat. Behav Brain Res 1997, 84:291-299.
79. Broersen L.M., Heinsbroek R.P.W., de Bruin J.P.C., Uylings H.B.M., Olivier B. The role of the medial prefrontal cortex of rats in short-term memory functioning: further support for involvement of cholinergic, rather than dopaminergic mechanisms. Brain Res 1995, 674:221-229.
80. Ragozzino M.E., Kesner R.P. The effects of muscarinic cholinergic receptor blockade in the rat anterior cingulate and prelimbic/infralimbic cortices on spatial working memory. Neurobiol Learn Mem 1998, 69:241-257.
81. Gutiérrez R., Rodriguez-Ortiz C.J., De La Cruz V., Núnez-Jaramillo L., Bermudez-Rattoni F. Cholinergic dependence of taste memory formation: evidence of two distinct processes. Neurobiol Learn Mem 2003, 80:323-331.
82. Ramírez-Lugo L., Miranda M.I., Escobar M.L., Espinosa E., Bermúdez-Rattoni F. The role of cortical cholinergic pre- and post-synaptic receptors in taste memory formation. Neurobiol Learn Mem 2003, 79:184-193.
83. Naor C., Dudai Y. Transient impairment of cholinergic function in the rat insular cortex disrupts the encoding of taste in conditioned taste aversion. Behav Brain Res 1996, 79:61-67.
84. Smythe J.W., Bhatnagar S., Murphy D., Timothy C., Costall B. The effects of intrahippocampal scopolamine infusions on anxiety in rats as measured by the black-white box test. Brain Res Bull 1998, 45:89-93.
85. File S.E., Gonzalez L.E., Andrews N. Endogenous acetylcholine in the dorsal hippocampus reduces anxiety through actions on nicotinic and muscarinic1 receptors. Behav Neurosci 1998, 112:352-359.
86. Brito G.N.O., Davis B.J., Stopp L.C., Stanton M.E. Memory and the septo-hippocampal cholinergic system in the rat. Psychopharmacology (Berl) 1983, 81:315-320.
87. Mishima K., Iwasaki K., Tsukikawa H., Matsumoto Y., Egashira N., Abe K., et al. The scopolamine-induced impairment of spatial cognition parallels the acetylcholine release in the ventral hippocampus in rats. Jpn J Pharmacol 2000, 84:163-173.
88. Herrera-Morales W., Mar I., Serrano B., Bermúdez-Rattoni F. Activation of hippocampal postsynaptic muscarinic receptors is involved in long-term spatial memory formation. Eur J Neurosci 2007, 25:1581-1588.
89. Markowska A.L., Olton D.S., Givens B. Cholinergic manipulations in the medial septal area: age-related effects on working memory and hippocampal electrophysiology. J Neurosci 1995, 15:2063-2073.
90. Givens B., Olton D.S. Bidirectional modulation of scopolamine-induced working memory impairments by muscarinic activation of the medial septal area. Neurobiol Learn Mem 1995, 63:269-276.
91. Ingles J.L., Beninger R.J., Jhamandas K., Boegman R.J. Scopolamine injected into the rat amygdala impairs working memory in the double Y-maze. Brain Res Bull 1993, 32:339-344.
92. Ohno M., Yamamoto T., Watanabe S. Amygdaloid NMDA and muscarinic receptors involved in working memory performance of rats. Physiol Behav 1993, 54:993-997.
93. McIntyre C.K., Ragozzino M.E., Gold P.E. Intra-amygdala infusions of scopolamine impair performance on a conditioned place preference task but not a spatial radial maze task. Behav Brain Res 1998, 95:219-226.
94. Carli M., Luschi R., Samanin R. (S)-WAY 100135, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine. Eur J Pharmacol 1995, 283:133-139.
95. Carli M., Luschi R., Samanin R. Dose-related impairment of spatial learning by intrahippocampal scopolamine: antagonism by odansetron, a 5-HT3 receptor antagonist. Behav Brain Res 1997, 82:185-194.
96. Carli M., Balducci C., Millan M.J., Bonalumi P., Samanin R. S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine. Br J Pharmacol 1999, 128:1207-1214.
97. Hamilton L.W., Grossman S.P. Behavioral changes following disruption of central cholinergic pathways. J Comp Physiol Psychol 1969, 69:76-82.
98. Elvander E., Schött P.A., Sandin J., Bjelke B., Kehr J., Yoshitake T., et al. Intraseptal muscarinic ligands and galanin: influence on hippocampal acetylcholine and cognition. Neuroscience 2004, 126:541-557.
99. Bermúdez-Rattoni F., Coburn K.L., Fernandez J., Chavez A.F., Garcia J. Potentiation of odor by taste and odor aversions in rats are regulated by cholinergic activity of dorsal hippocampus. Pharmacol Biochem Behav 1987, 26:553-559.
100. Blokland A., Honig W., Raaijmakers W.G.M. Effects of intra-hippocampal scopolamine injections in a repeated spatial acquisition task in the rat. Psychopharmacology (Berl) 1992, 109:373-376.
101. Rogers J.L., Kesner R.P. Cholinergic modulation of the hippocampus during encoding and retrieval of tone/shock-induced fear conditioning. Learn Mem 2004, 11:102-107.
102. Bermúdez-Rattoni F., Mujica Gonzalez M., Prado Alcala R.A. Is cholinergic activity of the striatum involved in the acquisition of positively-motivated behaviors?. Pharmacol Biochem Behav 1986, 24:715-719.
103. Carballo-Márquez A., Vale-Martínez A., Guillazo-Blanch G., Martí-Nicolovius M. Muscarinic transmission in the basolateral amygdala is necessary for the acquisition of socially transmitted food preferences in rats. Neurobiol Learn Mem 2009, 91:98-101.
104. Pratt W.E., Kelley A.E. Nucleus accumbens acetylcholine regulates appetitive learning and motivation for food via activation of muscarinic receptors. Behav Neurosci 2004, 118:730-739.
105. Boix-Trelis N., Vale-Martínez A., Guillazo-Blanch G., Martí-Nicolovius M. Muscarinic cholinergic receptor blockade in the rat prelimbic cortex impairs the social transmission of food preference. Neurobiol Learn Mem 2007, 87:659-668.
106. Gutiérrez R., De la Cruz V., Rodriguez-Ortiz C.J., Bermudez-Rattoni F. Perirhinal cortex muscarinic receptor blockade impairs taste recognition memory formation. Learn Mem 2004, 11:95-101.
107. Winters B.D., Bartko S.J., Saksida L.M., Bussey T.J. Scopolamine infused into perirhinal cortex improves object recognition memory by blocking the acquisition of interfering object information. Learn Mem 2007, 14:590-596.
108. Riekkinen P., Kuitunen J., Riekkinen M. Effects of scopolamine infusions into the anterior and posterior cingulate on passive avoidance and water maze navigation. Brain Res 1995, 685:46-54.
109. Hahn B., Shoaib M., Stolerman I.P. Involvement of the prefrontal cortex but not the dorsal hippocampus in the attention-enhancing effects of nicotine in rats. Psychopharmacology (Berl) 2003, 168:271-279.
110. Nott A., Levin E.D. Dorsal hippocampal α7 and α4β2 nicotinic receptors and memory. Brain Res 2006, 1081:72-78.
111. Levin E.D., Bradley A., Addy N., Sigurani N. Hippocampal α7 and α4β2 nicotinic receptors and working memory. Neuroscience 2002, 109:757-765.
112. Bettany J.H., Levin E.D. Ventral hippocampal α7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm maze. Pharmacol Biochem Behav 2001, 70:467-474.
113. Kim J.S., Levin E.D. Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: effects on spatial working memory in rats. Brain Res 1996, 725:231-240.
114. Felix R., Levin E.D. Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats. Neuroscience 1997, 81:1009-1077.
115. Bancroft A., Levin E.D. Ventral hippocampal α4β2 nicotinic receptors and chronic nicotine effects on memory. Neuropharmacology 2000, 39:2770-2778.
116. Ohno M., Yamamoto T., Shigenori W. Blockade of hippocampal nicotinic receptors impairs working but not reference memory in rats. Pharmacol Biochem Behav 1993, 45:89-93.
117. Addy N.A., Nakijama A., Levin E.D. Nicotinic mechanisms of memory: effects of acute local DHβE and MLA infusions in the basolateral amygdala. Cognitive Brain Res 2003, 16:51-57.
118. Levin E.D., Briggs S.J., Christopher N.C., Auman J.T. Working memory performance and cholinergic effects in the ventral tegmental area and substantia nigra. Brain Res 1994, 657:165-170.
119. Cannady R., Weir R., Wee B., Gotschlich E., Kolia N., Lau E., et al. Nicotinic antagonist effects in the mediodorsal thalamic nucleus: regional heterogeneity of nicotinic receptor involvement in cognitive function. Biochem Pharmacol 2009, 78:788-794.
120. Tucci S.A., Genn R.F., File S.E. Methyllycaconitine (MLA) blocks the nicotine evoked anxiongenic effect and 5-HT release in the dorsal hippocampus: possible role of α7 receptors. Neuropharmacology 2003, 44:367-373.
121. Vago D.R., Kesner R.P. Cholinergic modulation of pavlovian fear conditioning in rats: differential effects of intrahippocampal infusion of mecamylamine and methyllycaconitine. Neurobiol Learn Mem 2007, 87:441-449.
122. Cheeta S., Kenny P.J., File S.E. Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety. Prog Neuro-Psychoph 2000, 24:1053-1067.
123. File S.E., Cheeta S., Kenny P.J. Neurobiological mechanisms by which nicotine mediates different types of anxiety. Eur J Pharmacol 2000, 393:231-236.
124. File S.E., Kenny P.J., Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol Biochem Behav 2000, 66:65-72.
125. Cheeta S., Tucci S., File S.E. Antagonism of the anxiolytic effect of nicotine in the dorsal raphé nucleus by di-hyrdo-β-erythroidine. Pharmacol Biochem Behav 2001, 70:491-496.
126. Ouagazzal A.M., Kenny P.J., File S.E. Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety. Eur J Neurosci 1999, 11:3957-3962.
127. Reavill C., Stolerman I.P. Locomotor activity in rats after administration of nicotinic agonists intracerebrally. Br J Pharmacol 1990, 99:273-278.
128. Heishman S.J., Kleykamp B.A., Singleton E.G. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) 2010, 210:453-469.
129. Thiel C.M., Zilles K., Fink G.R. Nicotine modulates reorienting of visuospatial attention and neural activity in human parietal cortex. Neuropsychopharmacology 2005, 30:810-820.
130. Thienel R., Voss B., Kellermann T., Reske M., Halfter S., Sheldrick A.J., et al. Nicotinic antagonist effects on functional attention networks. Int J Neuropsychopharmacol 2009, 12:1295-1305.
131. Hahn B., Ross T.J., Wolkenberg F.A., Shakleya D.M., Huestis M.A., Stein E.A. Performance effects of nicotine during selective attention, divided attention, and simple stimulus detection: an fMRI study. Cereb Cortex 2009, 19:1990-2000.
132. Fredrickson A., Snyder P.J., Cromer J., Thomas E., Lewis M., Maruff P. The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine. Hum Psychopharmacol 2008, 23:425-436.
133. Furey M.L., Pietrini P., Haxby J.V., Drevets W.C. Selective effects of cholinergic modulation on task performance during selective attention. Neuropsychopharmacology 2008, 33:913-923.
134. Thienel R., Kellermann T., Schall U., Voss B., Reske M., Halfter S., et al. Muscarinic antagonist effects on executive control of attention. Int J Neuropsychopharmacol 2009, 12:1307-1317.
135. Lawrence N.S., Ross T.J., Stein E.A. Cognitive mechanisms of nicotine on visual attention. Neuron 2002, 36:539-548.
136. Hahn B., Ross T.J., Yang Y., Kim I., Huestis M.A., Stein E.A. Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network. J Neurosci 2007, 27:3477-3489.
137. Thiel C.M., Fink G.R. Effects of the cholinergic agonist nicotine on reorienting of visual spatial attention and top-down attentional control. Neuroscience 2008, 152:381-390.
138. Bentley P., Vuilleumier P., Thiel C.M., Driver J., Dolan R.J. Cholinergic enhancement modulates neural correlates of selective attention and emotional processing. Neuroimage 2003, 20:58-70.
139. Bentley P., Husain M., Dolan R.J. Effects of cholinergic enhancement on visual stimulation, spatial attention, and spatial working memory. Neuron 2004, 41:969-982.
140. Bentley P., Driver J., Dolan R.J. Modulation of fusiform cortex activity by cholinesterase inhibition predicts effects on subsequent memory. Brain 2009, 132:2356-2371.
141. Winterer G., Musso F., Konrad A., Vucurevic G., Stoeter P., Sander T., et al. Association of attentional network function with exon 5 variations of the CHRNA4 gene. Hum Mol Genet 2007, 16:2165-2174.
142. Xu J., Mendrek A., Cohen M.S., Monterosso J., Simon S., Brody A.L., et al. Effects of acute smoking on brain activity vary with abstinence in smokers performing the N-back task: a preliminary study. Psychiat Res: Neuroim 2006, 148:103-109.
143. Ernst M., Matochik J.A., Heishman S.J., Van Horn J.D., Jons P.H., Henningfield J.E., et al. Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci USA 2001, 98:4728-4733.
144. Kumari V., Gray J.A., Ffytche D.H., Mitterschiffthaler M.T., Das M., Zachariah E., et al. Cognitive effects of nicotine in humans: an fMRI study. Neuroimage 2003, 19:1002-1013.
145. Dumas J.A., Saykin A.J., McDonald B.C., McAllister T.W., Hynes M.L., Newhouse P.A. Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women. Am J Geriatr Psychiatry 2008, 16:272-282.
146. Furey M.L., Pietrini P., Haxby J.V. Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 2000, 290:2315-2319.
147. Schon K., Atri A., Hasselmo M.E., Tricarico M.D., LoPresti M.L., Stern C.E. Scopolamine reduces persistent activity related to long-term encoding in the parahippocampal gyrus during delayed matching in humans. J Neurosci 2005, 25:9112-9123.
148. Chuah L.Y.M., Chong D.L., Chen A.K., Rekshan W.R., Tan J.C., Zheng H., et al. Donepezil improves episodic memory in young individuals vulnerable to the effects of sleep deprivation. Sleep 2009, 32:999-1010.
149. Kukolja J., Thiel C.M., Fink G.R. Cholinergic stimulation enhances neural activity associated with encoding but reduces neural activity associated with retrieval in humans. J Neurosci 2009, 29:8119-8128.
150. Sperling R., Greve D., Dale A., Killiany R., Holmes J., Rosas H.D., et al. Functional MRI detection of pharmacologically induced memory impairment. Proc Natl Acad Sci USA 2002, 99:455-460.
151. Bozzali M., MacPherson S.E., Dolan R.J., Shallice T. Left prefrontal cortex control of novel occurences during recollection: a psychopharmacological study using scopolamine and event-related fMRI. Neuroimage 2006, 33:286-295.
152. Rosier A.M., Cornette L., Dupont P., Bormans G., Mortelmans L., Orban G.A. Regional brain activity during shape recognition impaired by a scopolamine challenge to encoding. Eur J Neurosci 1999, 11:3701-3714.
153. Thiel C.M., Henson R.N.A., Dolan R.J. Scopolamine but not lorazepam modulates face repetition priming: a psychopharmacological fMRI study. Neuropsychopharmacol 2002, 27:282-292.
154. Mentis M.J., Sunderland T., Lai J., Connolly C., Krasuski J., Levine B., et al. Muscarinic versus nicotinic modulation of a visual task. A pet study using drug probes. Neuropsychopharmacology 2001, 25:555-564.
155. Knight R.T. Neural networks debunk phrenology. Science 2007, 316:1578-1579.